References
- Al-Delaimy WK, Jansen EH, Peeters PH, et al. (2006). Reliability of biomarkers of iron status, blood lipids, oxidative stress, vitamin D, C-reactive protein and fructosamine in two Dutch cohorts. Biomarkers 11:370–82
- Beard J. (2001). Iron status of free-living elderly individuals. Am J Clin Nutr 73:503–4
- Bobrowicz E, Naskalski JW, Siedlecki A. (2001). Preanalytical factors in human plasma ascorbate assay. Clin Chim Acta 314:237–9
- Cade JE, Moreton JA, O’Hara B, et al. (2005). Diet and genetic factors associated with iron status in middle-aged women. Am J Clin Nutr 82:813–20
- Corti MC, Gaziano M, Hennekens CH. (1997). Iron status and risk of cardiovascular disease. Ann Epidemiol 7:62–8
- Donnelly JG, Soldin SJ, Nealon DA, Hicks, JM. (1995). Stability of twenty-five analytes in human serum at 22, 4 and −20 degrees C. Pediatr Pathol Lab Med 15:869–74
- Drammeh BS, Schleicher RL, Pfeiffer CM, et al. (2008). Effects of delayed sample processing and freezing on serum concentrations of selected nutritional indicators. Clin Chem 54:1883–91
- Fleming DJ, Jacques PF, Tucker KL, et al. (2001). Iron status of the free-living, elderly Framingham Heart Study cohort: an iron-replete population with a high prevalence of elevated iron stores. Am J Clin Nutr 73:638–46
- Gislefoss RE, Grimsrud TK, Morkrid L. (2008). Long-term stability components in the Janus Serum Bank. Scand J Clin Lab Invest 68:402–9
- Hercberg S, Estaquio C, Czernichow S, et al. (2005). Iron status and risk of cancers in the SU.VI.MAX cohort. J Nutr 135:2664–8
- Jansen EHJM, Beekhof PK, Cremers JWJM, Schenk E. (2012). Long-term (in)stability of folate and vitamin B12 in human serum. Clin Chem Lab Med 50:1761–5
- Joosten E, Meeuwissen J, Vandewinckele H, Hiele M. (2008). Iron status and colorectal cancer in symptomatic elderly patients. Am J Med 121:1072–7
- Lippi G, Chance JJ, Church S, et al. (2011). Preanalytical quality improvement: from dream to reality. Clin Chem Lab Med 49:1113–26
- Liyanarachcy NM. (2000). Effects of storage at 4 °C for seven days on ten serum analytes. NZ J Med Lab Sci 54:83–6
- Mathew G, Zwart SR, Smith SM. (2009). Stability of blood analytes after storage in BD SST tubes for 12 mo. Clin Biochem 42:1732–4
- O’Doherty MG, Abnet CC, Murray LJ, et al. (2010). Iron intake and markers of iron status and risk of Barrett’s esophagus and esophageal adenocarcinoma. Cancer Causes Control 21:2269–79
- Ramakrishnan U, Kuklina E, Stein AD. (2002). Iron stores and cardiovascular disease risk factors in women of reproductive age in the United States. Am J Clin Nutr 76:1256–60
- Salonen JT, Nyyssönen K, Korpela H, et al. (1992). High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 86:803–11
- Sempos CT, Looker AC, Gillum RF, Makuc DM. (1994). Body iron stores and the risk of coronary heart disease. N Engl J Med 330:1119–24
- Stoddard L, Dennis W, Parvin RM, van Assendelft OW. (1984). Freeze/thaw stability of transferrin, and reference values obtained with kinetic nephelometry. Clin Chem 30:114–15
- Tanner M, Kent N, Smith B, et al. (2008). Stability of common biochemical analytes in serum gel tubes subjected to various storage temperatures and times pre-centrifugation. Ann Clin Biochem 45:375–9
- Wish JB. (2006). Assessing iron status: beyond serum ferritin and transferrin saturation. Clin J Am Soc Nephrol 1:S4–8
- Weinberg ED. (1996). The role of iron in cancer. Eur J Cancer Prev 5:19–36